Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Penetration of the Innovative Antibiotic Gepotidacin Into Prostate and Tonsillar Tissue.

NCT04484740 is registered in ClinicalTrials.gov with Institut National de la Santé Et de la Recherche Médicale, France as lead sponsor.

NCT NCT04484740
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04484740 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Penetration of the Innovative Antibiotic Gepotidacin Into Prostate and Tonsillar Tissue.
Lead sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Phase
Phase 1
Overall status
Completed
Start date
January 29, 2021
Completion date
May 27, 2023
Enrollment
53 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

gonorrhea, infection, bacterial